The Time for $5 Coalition calls out Cepheid for not including price reductions of Xpert tests in their updated GeneXpert pricing packages for low- and middle-income countries.

A shorter regimen containing rifapentine and moxifloxacin can cure TB in four months.

TAG and AfroCAB are inviting applications from treatment activists and community leaders for a new cross-disease long-acting technologies community advisory board. The deadline to apply is 21 May 2021.

Urgent actions to stop preventable deaths and suffering due to TB and recover gains lost during the COVID-19 pandemic.

The new Global Plan will cover the period 2023 to 2030 and will specifically identify what resources are needed to end the TB epidemic globally.

The Roadmap identifies priorities for the development and implementation of new TB vaccines with the aim to coordinate and accelerate global action.

A new technical guide addresses critical gaps in TB care and control by focusing on overcoming the psychological, social and economic factors that prevent people from accessing diagnosis, adhering to care plans and successfully completing treatment.

Global Fund surveys in 13 countries with the highest TB burden in the world reveal that 29% fewer people were tested for TB compared to 2019.

An estimated 1.4 million fewer people received care for TB in 2020 than in 2019 - a reduction of 21% from 2019, according to preliminary data compiled by the World Health Organization.

TB burden in the WHO European Region as a whole is decreasing. However, TB is second only to COVID-19 as an infectious disease that kills, and drug resistance is a major concern.